These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2966 related items for PubMed ID: 17912165

  • 1. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
    Morrison DA, Berman M, El-Amin O, McLaughlin RT, Bates ER.
    Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
    [Abstract] [Full Text] [Related]

  • 2. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India.
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [Abstract] [Full Text] [Related]

  • 3. Multivessel percutaneous coronary intervention: a new paradigm for a new century.
    Morrison DA.
    Minerva Cardioangiol; 2005 Oct; 53(5):361-77. PubMed ID: 16179881
    [Abstract] [Full Text] [Related]

  • 4. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
    Silber S, Richartz BM, Brilmayer M, European Society of Cardiology (ESC).
    Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet intervention in acute coronary syndrome.
    Arora RR, Rai F.
    Am J Ther; 2009 Dec; 16(5):e29-40. PubMed ID: 19092648
    [Abstract] [Full Text] [Related]

  • 6. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S, Hoffmeister HM, Bode C.
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [Abstract] [Full Text] [Related]

  • 7. Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?
    Valgimigli M, Airoldi F, Zimarino M.
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10 Suppl 1():S17-26. PubMed ID: 19851216
    [Abstract] [Full Text] [Related]

  • 8. PCI versus CABG versus medical therapy in 2006.
    Morrison D.
    Minerva Cardioangiol; 2006 Oct; 54(5):643-72. PubMed ID: 17019400
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI, McKay RG, Boden WE, Mather JF, White CM.
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [Abstract] [Full Text] [Related]

  • 10. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA, Sacks J.
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [Abstract] [Full Text] [Related]

  • 11. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W, European Society of Cardiology.
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [Abstract] [Full Text] [Related]

  • 12. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study.
    Zhang Q, Zhang RY, Qiu JP, Jin HG, Zhang JF, Wang XL, Jiang L, Liao ML, Hu J, Ding FH, Zhang JS, Shen WF.
    Chin Med J (Engl); 2009 Mar 20; 122(6):636-42. PubMed ID: 19323926
    [Abstract] [Full Text] [Related]

  • 13. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, Browne K, Iwaoka R, Azrin M, Stapleton D, Setum C, Popma J, AIMI Investigators.
    J Am Coll Cardiol; 2006 Jul 18; 48(2):244-52. PubMed ID: 16843170
    [Abstract] [Full Text] [Related]

  • 14. [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].
    Silber S.
    Herz; 2010 Dec 18; 35(8):558-64. PubMed ID: 21107514
    [Abstract] [Full Text] [Related]

  • 15. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ.
    Kardiol Pol; 2006 Aug 18; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV, Herzinfarktverbund Essen.
    Herz; 2008 Mar 18; 33(2):136-42. PubMed ID: 18344033
    [Abstract] [Full Text] [Related]

  • 17. Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries.
    Roe MT, Chen AY, Cannon CP, Rao S, Rumsfeld J, Magid DJ, Brindis R, Klein LW, Gibler WB, Ohman EM, Peterson ED, CRUSADE and ACTION-GWTG Registry Participants.
    Circ Cardiovasc Qual Outcomes; 2009 Sep 18; 2(5):414-20. PubMed ID: 20031871
    [Abstract] [Full Text] [Related]

  • 18. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Zhang Q, Zhang RY, Qiu JP, Zhang JF, Wang XL, Jiang L, Liao ML, Zhang JS, Hu J, Yang ZK, Shen WF.
    Chin Med J (Engl); 2008 Mar 20; 121(6):485-91. PubMed ID: 18364130
    [Abstract] [Full Text] [Related]

  • 19. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F, Kovárník T, Aschermann M, Simek S, Linhart A, Humhal J, Skulec R, Reznícek V.
    Vnitr Lek; 2002 May 20; 48(5):373-9. PubMed ID: 12061202
    [Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Sinno MC, Khanal S, Al-Mallah MH, Arida M, Weaver WD.
    Am Heart J; 2007 Apr 20; 153(4):579-86. PubMed ID: 17383297
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 149.